• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1978-2009 年丹麦对侧乳腺癌的发病情况。

Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.

机构信息

Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark, Department of Gynecology, Department of Oncology and Danish Breast Cancer Cooperative Group, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark, Department of Gynecology, Department of Oncology and Danish Breast Cancer Cooperative Group, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark, Department of Gynecology, Department of Oncology and Danish Breast Cancer Cooperative Group, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

出版信息

Int J Epidemiol. 2014 Dec;43(6):1855-64. doi: 10.1093/ije/dyu202. Epub 2014 Oct 16.

DOI:10.1093/ije/dyu202
PMID:25326461
Abstract

BACKGROUND

Incidence of contralateral breast cancer (CBC) is much less studied than primary breast cancer. We aimed to assess incidence rates of CBC in relation to age, calendar period and time since first breast cancer.

METHODS

Using the nationwide Danish Cancer Registry, we identified 85 863 women with a first primary invasive breast cancer without distant metastases in Denmark during 1978-2009. Among these, 3120 women developed metachronous CBC. Crude incidence rates for CBC were calculated by age and calendar period at first breast cancer as well as time since first breast cancer. Mutual adjustments were made by use of Poisson regression models.

RESULTS

The incidence of CBC decreased with increasing age at first breast cancer. Before 1998, incidence rates of CBC showed little variation. The rates decreased by period of first primary from 546 per 10(5) person-years in 1993-97 to 328 per 10(5) person-years in 2003-09. After adjustment for age and calendar period, no clear trend was observed in the overall incidence according to time since first breast cancer.

CONCLUSIONS

Occurrence of cancer in the contralateral breast seems to be rather independent of time passed since the first primary. The finding of a decreasing incidence of CBC after 1997 is likely to be due to more women receiving systemic adjuvant therapy such as tamoxifen and longer duration of this treatment as well as the introduction of aromatase inhibitors.

摘要

背景

与原发性乳腺癌相比,对侧乳腺癌(CBC)的发病率研究得较少。我们旨在评估与年龄、日历时间和首次乳腺癌后时间相关的 CBC 发病率。

方法

使用全国性的丹麦癌症登记处,我们确定了 1978-2009 年期间在丹麦首次患有原发性浸润性乳腺癌且无远处转移的 85863 名女性。其中,3120 名女性发生了异时性 CBC。通过首次乳腺癌的年龄和日历时间以及首次乳腺癌后的时间计算 CBC 的粗发病率。使用泊松回归模型进行相互调整。

结果

CBC 的发病率随首次乳腺癌年龄的增加而降低。1998 年前,CBC 的发病率变化不大。首次原发性的发病时间从 1993-97 年的每 105 人年 546 例降至 2003-09 年的每 105 人年 328 例。在调整年龄和日历时间后,根据首次乳腺癌后的时间,总体发病率没有明显趋势。

结论

对侧乳房发生癌症的情况似乎与首次原发性肿瘤后经过的时间相当独立。1997 年后 CBC 发病率下降的发现可能是由于更多的女性接受了他莫昔芬等全身性辅助治疗,且这种治疗的持续时间更长,以及芳香化酶抑制剂的引入。

相似文献

1
Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.1978-2009 年丹麦对侧乳腺癌的发病情况。
Int J Epidemiol. 2014 Dec;43(6):1855-64. doi: 10.1093/ije/dyu202. Epub 2014 Oct 16.
2
Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.苏黎世州异时性对侧乳腺癌的发病率:一项基于人群的癌症登记研究。
J Cancer Res Clin Oncol. 2016 Feb;142(2):365-71. doi: 10.1007/s00432-015-2031-1. Epub 2015 Aug 23.
3
Second primary in the contralateral breast after treatment of breast cancer.乳腺癌治疗后对侧乳房出现第二原发性肿瘤。
Radiother Oncol. 2008 Feb;86(2):171-6. doi: 10.1016/j.radonc.2007.10.002. Epub 2007 Oct 24.
4
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.辅助治疗对患侧乳腺癌风险的影响及对侧乳腺癌的预后意义:荷兰一项基于人群的研究
Breast Cancer Res Treat. 2008 Jul;110(1):189-97. doi: 10.1007/s10549-007-9709-2. Epub 2007 Aug 9.
5
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.1975 年至 2006 年美国对侧乳腺癌发病率下降。
J Clin Oncol. 2011 Apr 20;29(12):1564-9. doi: 10.1200/JCO.2010.32.7395. Epub 2011 Mar 14.
6
Risk of contralateral breast cancer after tamoxifen use among Danish women.丹麦妇女使用他莫昔芬后对侧乳腺癌的风险。
Ann Epidemiol. 2014 Nov;24(11):843-8. doi: 10.1016/j.annepidem.2014.08.003. Epub 2014 Sep 6.
7
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.WECARE研究中乳腺癌的全身治疗与后续对侧乳腺癌风险
Breast Cancer Res. 2016 Jul 12;18(1):65. doi: 10.1186/s13058-016-0726-0.
8
Clinical and histological predictors of contralateral breast cancer.对侧乳腺癌的临床和组织学预测因素
Eur J Surg Oncol. 1999 Dec;25(6):584-9. doi: 10.1053/ejso.1999.0711.
9
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.在未接受辅助性他莫昔芬治疗的患者中,对侧乳腺癌的激素受体状态独立于首个原发性肿瘤的受体状态。
J Clin Oncol. 2005 Jul 20;23(21):4687-94. doi: 10.1200/JCO.2005.04.076. Epub 2005 Apr 18.
10
Reproductive history and risk of second primary breast cancer: the WECARE study.生育史与第二原发性乳腺癌风险:WECARE研究
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):906-11. doi: 10.1158/1055-9965.EPI-06-1003.

引用本文的文献

1
Impact of postoperative complications and type 2 diabetes on breast cancer recurrence and mortality.术后并发症和2型糖尿病对乳腺癌复发及死亡率的影响。
Br J Surg. 2025 Aug 1;112(8). doi: 10.1093/bjs/znaf176.
2
Age-Related Incidence and Peak Occurrence of Contralateral Breast Cancer.与年龄相关的对侧乳腺癌发病和发病高峰。
JAMA Netw Open. 2023 Dec 1;6(12):e2347511. doi: 10.1001/jamanetworkopen.2023.47511.
3
Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer.韩国乳腺癌患者对侧乳腺癌发生后的生存情况。
JAMA Netw Open. 2023 Sep 5;6(9):e2333557. doi: 10.1001/jamanetworkopen.2023.33557.
4
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.乳腺癌患者首次诊断后 10-32 年内的复发情况。
J Natl Cancer Inst. 2022 Mar 8;114(3):391-399. doi: 10.1093/jnci/djab202.
5
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.早期乳腺癌治疗后老年患者个体化监测乳腺 X 线摄影:多学科专家小组和国际老年肿瘤学会共识声明。
JAMA Oncol. 2021 Apr 1;7(4):609-615. doi: 10.1001/jamaoncol.2020.7582.
6
Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries.使用丹麦医学登记处确定晚期乳腺癌复发的算法验证
Clin Epidemiol. 2020 Oct 14;12:1083-1093. doi: 10.2147/CLEP.S269962. eCollection 2020.
7
Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal.原发性乳腺癌切除术后再次手术后的远处转移动力学。
Breast Cancer Res. 2019 May 2;21(1):57. doi: 10.1186/s13058-019-1139-7.
8
Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models.肥胖相关癌症:机制研究和啮齿动物模型中的当前知识、挑战与局限
Cancers (Basel). 2018 Dec 18;10(12):523. doi: 10.3390/cancers10120523.
9
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.从双侧乳腺癌的肿瘤相关基因表达变异性中解析时间
Int J Mol Sci. 2018 Jan 9;19(1):196. doi: 10.3390/ijms19010196.
10
Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance.一个中等收入亚洲国家对侧乳腺癌的低终生风险:指导治疗后监测的证据
World J Surg. 2018 May;42(5):1270-1277. doi: 10.1007/s00268-017-4319-6.